Human single domain antibody-based CAR-T cells targeting BAFF-R demonstrate promising preclinical activity in B-cell malignancies. Zhang C, Luo Q, Wu S, Xu L, et al. BMC Cancer 2026;26:1125.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang C, Luo Q, Wu S, Xu L, et al. Human single domain antibody-based CAR-T cells targeting BAFF-R demonstrate promising preclinical activity in B-cell malignancies. BMC Cancer 2026;26:1125.
PMID: 42387444